Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Exagen

Exagen

Sep 25, 2019

IPO Window Wide Open for Dx, Genomics Companies

Premium

Industry experts say a receptive market and investor interest in new technologies have spurred the increase in genomics tools and molecular diagnostics IPOs. 

Nov 10, 2014

Exagen Records Sharp Increase in Revenues for First Nine Months of 2014

NEW YORK (GenomeWeb) – Exagen Diagnostics said in a regulatory document that its revenues through the first nine months of 2014 grew almost four-fold year over year.

Sep 24, 2014

People in the News: Olivier Danos, Frank Witney, John Radak

Premium

Biogen Idec has hired Olivier Danos as senior VP of gene therapy. Danos will report to Douglas Williams, executive VP of R&D at Biogen Idec. At Biogen Idec, he will be in charge of the gene therapy research group, which develops new technologies for gene transfer and genome engineering.

Jul 22, 2014

Exagen Raises $3.95M

NEW YORK (GenomeWeb) – Rheumatology and autoimmune diagnostics firm Exagen Diagnostics has raised $3.95 million, it said in a regulatory document on Monday.

Oct 30, 2013

People in the News: Arthur Weinstein

Premium

Exagen Diagnostics, a rheumatology-focused diagnostics company, announced that Arthur Weinstein will become its newest board member and advise the company's scientific team.

Oct 18, 2013

Exagen Diagnostics Raises $5M

NEW YORK (GenomeWeb News) – Exagen Diagnostics this week said in a regulatory filing that it raised a little more than $5 million in an equity financing round.

Oct 25, 2012

New York Approves Exagen Lupus Test

NEW YORK (GenomeWeb News) – Exagen Diagnostics today said that New York has approved its Avise SLE diagnostic, SLE-Systemic Lupus Erythematosus.

Sep 11, 2012

Rheumatology Genomic Test Developer Exagen Diagnostics Raises $5.3M

NEW YORK (GenomeWeb News) – Exagen Diagnostics, which develops genomic tests aimed at rheumatology, announced on Monday the completion of a financing round that raised $5.3 million.

Jan 28, 2011

In Brief This Week: Genetic Technologies; Exagen Diagnostics; NorDiag, Hain Lifescience

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Oct 11, 2010

Genomic Tests Firm Exagen Buying Cypress’ Dx Biz

Exagen will pay Cypress up to $8 million in upfront and milestone payments as well as additional royalty payments for the business.

Pages

The Scan

This Time, Novamax

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.